Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

Stockholders’ Equity (Tables)

12 Months Ended

Jul. 31, 2024

The below is a summary of the option activity pursuant to the Company’s stock option plan and non-plan options for the years ended July 31, 2024 and 2023:

	2024					2023
	Options			Weighted - Average Exercise Price		Options			Weighted - Average Exercise Price
Outstanding at beginning of year		3,829,500		$	2.61		3,941,783		$	3.00
New Grants		435,000		$	1.80		640,000		$	2.01
Exercised		—		$	—		(6,667	)	$	2.14
Expired or forfeited		(2,127,630	)	$	1.58		(745,616	)	$	4.15
Outstanding at end of year		2,136,870		$	2.31		3,829,500		$	2.61
Exercisable at end of year		1,373,537		$	2.44		2,195,867		$	2.65
Weighted average fair value of options granted during year				$	0.51				$	1.03

Schedule of Assumptions Used to Determine the Fair Value of Options Granted

Listed below are the assumptions used to determine the fair value of options granted during fiscal years 2024 and 2023:

Grant Year

Options
Granted

Exercise
Price
Range

Term
(years)

Vesting
Period
(years)

FMV of
Options
Granted/Per
Share

Expected
Life
(years)

Expected
Volatility
%

Interest
Rate
%

2024

435,000

$ 1.11 – $2.00

$0.39 – $0.73

3.5

70.00% – 73.25

4.85 – 5.20

2023

640,000

$ 1.97 – $2.42

$1.07 – $1.28

3.5

73.44 – 73.77

3.03 – 4.10

Schedule of Stock Options Exercisable and Outstanding

The following table summarizes information for stock options exercisable at July 31, 2024:

Range of Exercise prices	Shares		Weighted- Average Remaining Contractual Life in Years		Weighted- Average Exercise Price
$1.11 - $2.33		724,900		1.8	$	2.18
$2.63 - $2.65		530,470		1.2	$	2.64
$2.98 - $3.36		118,167		2.6	$	3.17
		1,373,537

The following table summarizes information for stock options outstanding at July 31, 2024:

Range of Exercise prices	Shares		Weighted- Average Remaining Contractual Life in Years		Weighted- Average Exercise Price
$1.11 - $2.33		1,429,900		2.4	$	2.08
$2.63 - $2.65		530,470		1.2	$	2.64
$2.98 - $3.36		176,500		2.6	$	3.17
		2,136,870

Schedule of Restricted Stock Unit (“RSU”) Activity

The following table summarizes plan and non-plan RSU activity for the fiscal year ended July 31, 2024:

	Number of RSUs outstanding			Weighted Average Fair Value per Unit at Date of Grant or Vesting		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (000s)
Outstanding at beginning of fiscal year		557,490		$	2.21	1.1 years	$	825
Granted		405,825		$	1.31			532
Vested		(475,222	)	$	2.24
Cancelled		(179,363	)	$	1.66
Outstanding at end of period		308,730		$	1.31	1.5 years	$	352
Expected to vest at end of period		308,730		$	131	1.5 years	$	352